drugset / Trial / NCT05364931
A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of cotadutide in participants with non-cirrhotic NASH with fibrosis.
Timeline
- Start
- 2022-07-14
- Primary completion
- 2024-04-19
- Completion
- 2024-04-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cotadutide | Peptide | 300 ug | Subcutaneous |
| Subject | Cotadutide | Peptide | 600 ug | Subcutaneous |